Dataset Information


The nuclear receptor REV-ERB? modulates Th17 cell-mediated autoimmune disease.

ABSTRACT: T helper 17 (Th17) cells produce interleukin-17 (IL-17) cytokines and drive inflammatory responses in autoimmune diseases such as multiple sclerosis. The differentiation of Th17 cells is dependent on the retinoic acid receptor-related orphan nuclear receptor ROR?t. Here, we identify REV-ERB? (encoded by Nr1d1), a member of the nuclear hormone receptor family, as a transcriptional repressor that antagonizes ROR?t function in Th17 cells. REV-ERB? binds to ROR response elements (RORE) in Th17 cells and inhibits the expression of ROR?t-dependent genes including Il17a and Il17f Furthermore, elevated REV-ERB? expression or treatment with a synthetic REV-ERB agonist significantly delays the onset and impedes the progression of experimental autoimmune encephalomyelitis (EAE). These results suggest that modulating REV-ERB? activity may be used to manipulate Th17 cells in autoimmune diseases.

PROVIDER: S-EPMC6744854 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6400287 | BioStudies
2019-08-16 | GSE72271 | GEO
| S-EPMC4865262 | BioStudies
| S-EPMC4613749 | BioStudies
| S-EPMC3458568 | BioStudies
| S-EPMC4165400 | BioStudies
| S-EPMC2587175 | BioStudies
| S-EPMC3270375 | BioStudies
| S-EPMC6911370 | BioStudies
| S-EPMC5485243 | BioStudies